Selling and Marketing Expense of ORAMED PHARMACEUTICALS INC. from 30 Sep 2021 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
ORAMED PHARMACEUTICALS INC. quarterly Selling and Marketing Expense in USD history and change rate from 30 Sep 2021 to 30 Sep 2023.
  • ORAMED PHARMACEUTICALS INC. Selling and Marketing Expense for the quarter ending 30 Sep 2023 was $663,000, a 243% decline year-over-year.
Source SEC data
View on sec.gov
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Change (%)

ORAMED PHARMACEUTICALS INC. Quarterly Selling and Marketing Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $663,000 -$1,126,000 -243% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $192,000 -$188,000 -49% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $184,000 -$406,000 -69% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q3 2022 $2,331,000 $463,000 +$291,000 +169% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $2,040,000 $380,000 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $590,000 01 Jan 2022 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $898,000 01 Sep 2021 31 Dec 2021 10-QT 30 Mar 2022 2021 Q2
Q3 2021 $172,000 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.